Accounts Receivable, after Allowance for Credit Loss, Current of Medinotec Inc. from 28 Feb 2022 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Medinotec Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 28 Feb 2022 to 30 Nov 2025.
  • Medinotec Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Nov 2025 was $2,259,523, a 128% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Medinotec Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,259,523 +$1,267,059 +128% 30 Nov 2025 10-Q 09 Jan 2026 2026 Q3
Q3 2025 $2,575,271 +$1,803,903 +234% 31 Aug 2025 10-Q 08 Oct 2025 2026 Q2
Q2 2025 $3,886,756 +$3,528,077 +984% 31 May 2025 10-Q 16 Jul 2025 2026 Q1
Q1 2025 $2,612,440 +$2,022,679 +343% 28 Feb 2025 10-Q 09 Jan 2026 2026 Q3
Q4 2024 $992,464 +$916,234 +1202% 30 Nov 2024 10-Q 14 Jan 2025 2025 Q3
Q3 2024 $771,368 +$591,236 +328% 31 Aug 2024 10-Q 15 Oct 2024 2025 Q2
Q2 2024 $358,679 +$117,509 +49% 31 May 2024 10-Q 12 Jul 2024 2025 Q1
Q1 2024 $589,761 +$568,687 +2699% 29 Feb 2024 10-K 29 May 2025 2025 FY
Q4 2023 $76,230 -$207,171 -73% 30 Nov 2023 10-Q 14 Mar 2024 2024 Q3
Q3 2023 $180,132 31 Aug 2023 10-Q 13 Oct 2023 2024 Q2
Q2 2023 $241,170 31 May 2023 10-Q 14 Jul 2023 2024 Q1
Q1 2023 $21,074 -$21,109 -50% 28 Feb 2023 10-K 05 Jul 2024 2024 FY
Q4 2022 $283,401 30 Nov 2022 10-Q 17 Jan 2023 2023 Q3
Q1 2022 $42,183 28 Feb 2022 10-K 30 May 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.